Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea
· Delayed Price · Currency is KRW
7,020.00
+420.00 (6.36%)
Mar 10, 2026, 1:26 PM KST
Oncocross Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 80,493 | 75,179 | - | - | - | - |
| Enterprise Value | 58,800 | 62,376 | - | - | - | - |
| Last Close Price | 6600.00 | 6340.00 | - | - | - | - |
| PS Ratio | 90.99 | 70.12 | - | - | - | - |
| PB Ratio | 5.05 | 3.68 | - | - | - | - |
| P/TBV Ratio | 5.07 | 3.68 | - | - | - | - |
| EV/Sales Ratio | 66.46 | 58.18 | - | - | - | - |
| Debt / Equity Ratio | 0.32 | 0.03 | 0.01 | 0.05 | 0.20 | -1.14 |
| Net Debt / Equity Ratio | -1.36 | -0.99 | -1.00 | -1.00 | -1.08 | 0.18 |
| Net Debt / EBITDA Ratio | 2.59 | 3.08 | 2.59 | 0.70 | 1.70 | 0.75 |
| Net Debt / FCF Ratio | 2.27 | 3.55 | 3.36 | 0.79 | 1.84 | 0.80 |
| Asset Turnover | 0.04 | 0.05 | 0.01 | 0.01 | 0.01 | - |
| Quick Ratio | 9.18 | 11.35 | 15.16 | 4.47 | 7.87 | 1.05 |
| Current Ratio | 9.43 | 11.42 | 15.25 | 4.59 | 7.93 | 1.06 |
| Return on Equity (ROE) | -58.44% | -35.10% | -36.33% | -114.08% | - | - |
| Return on Assets (ROA) | -24.60% | -21.69% | -32.76% | -53.18% | -27.13% | - |
| Return on Capital Employed (ROCE) | -31.40% | -33.60% | -41.30% | -146.40% | -55.20% | -201.70% |
| Earnings Yield | -10.35% | -8.62% | - | - | - | - |
| FCF Yield | -11.89% | -7.56% | - | - | - | - |
| Buyback Yield / Dilution | -15.16% | -17.49% | -1.44% | -63.74% | -0.83% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.